Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostate Adenocarcinoma × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Select Advanced Solid Tumors 1 Sarcoma 1 Recurrence 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1

Interventions

atezolizumab 1 PROSTVAC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04020094 2021-09-22

AtezoVax

University of Utah

Phase 2 Withdrawn

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡